IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Valiant Laboratories IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 152.46 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Unistone Capital is the merchant banker of Valiant Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th June 2023.
Valiant Laboratories IPO open date is 27th September 2023 and close date is 3rd October 2023. IPO Allotment Date is 5th October 2023 and Listing date is 6th October 2023.
IPO
Size:
₹ 152.46 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Unistone Capital
IPO by BRLM so far:
13
City:
Mumbai
IPO so far:
184
Revenue (annualised):
₹
338.77
cr. 
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Valiant Laboratories IPO size is ₹ 152.46 Cr. with IPO price of ₹ 140.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Unistone Capital Private Limited is the book-running lead manager of the Valiant Laboratories IPO. Link Intime India Private Limited is the Registrar for Valiant Laboratories IPO.
Valiant Laboratories IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Valiant Laboratories IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on manufacturing of APIs and bulk drugs with a prime focus on paracetamol. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Valiant Laboratories IPO size is ₹ 152.46 Cr. with fresh issue size of ₹ 152.46 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Valiant Laboratories IPO is expected to be 5th October 2023, after the finalization of basis of allotment. Investors can check Valiant Laboratories IPO allotment status on the registrars website, Link Intime India Private Limited . Valiant Laboratories IPO refund dates are 6th October 2023.
Valiant Laboratories IPO is expected to be listed on 6th October 2023.
The upper price band for the Valiant Laboratories IPO is set at ₹ 140.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Valiant Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Valiant Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 3rd October 2023. After submission, funds are blocked until the basis of allotment of Valiant Laboratories IPO is finalised.
The merchant banker for Valiant Laboratories IPO is Unistone Capital Private Limited . Unistone Capital Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Valiant Laboratories IPO RHP for further details.
The registrar for Valiant Laboratories IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Valiant Laboratories IPO through their official website or helpline.
Valiant Laboratories IPO was subscribed 29.76 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 152.46 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Unistone Capital
IPO by BRLM so far:
13
City:
Mumbai
IPO so far:
184
Revenue (annualised):
₹ 333.91 cr.
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Valiant Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Valiant Laboratories Financial Review Page
Merchant Banker(s) of Valiant Laboratories IPO: Unistone Capital Private Limited
Valiant Laboratories IPO subscription was 29.76 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Valiant Laboratories IPO listed at a listing price of 169.05 against the offer price of 140.00.
The current market price of Valiant Laboratories is 119.90.
Why Us?
